WHO says a review of the interim results showed hydroxychloroquine and
lopinavir/ritonavir "produce little or no reduction in the mortality
of hospitalized COVID-19 patients when compared to standard of care."
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/who-ending-hydroxycholorquine-trial-for-covid/articleshow/76793349.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment